Research & Development

午夜福利视频合集1000男女啪啪视频在线啪啪啪视频观看免费抢抓注册制改革机遇 成都借势打造“科创军团”


  司馬遷可能覺得袖子很重,就鐺的一聲把沉重的袖子放在桌案上對雲瑯道︰“這樣做沒用的,只會讓關中的玉器價格飛漲,大漢國更加吃虧!”   “以前匈奴人定下的賦稅是多少?”午夜福利视频合集1000   春風早,看東南王氣,飛繞星躔。”男女啪啪视频在线   霍去病喝了一口茶水道︰“敵人太弱,看不出效果。”   一個水窪,可能八百人使用沒有問題,兩萬六千人使用就會出大問題。啪啪啪视频观看免费   東方朔把玩著一顆晶瑩剔透屁的玉石籽料道︰“這是宦囊!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo